Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CHRM1CHRM2CHRM3CHRM4ESR1ESR2GABRA1GABRB1GABRG2GBA1HRH1HTR1DHTR2AOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.45 |
| ▸ | PDE4A | P27815 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.40 |
| ▸ | F2 | P00734 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cadaverine Tartrate SCHEMBL30689288 | 1.00 | TSHR (1.00) | TSHRTP53CYP2C9PDE4ALMNA | |
| Tartaric Acid SCHEMBL29430365 | 1.00 | TSHR (1.00) | TSHRTP53CYP2C9PDE4ALMNA | |
| Cadaverine Tartrate SCHEMBL1062721 | 1.00 | TSHR (1.00) | TSHRTP53CYP2C9PDE4ALMNA | |
| Cadaverine Tartrate SCHEMBL22768 | 1.00 | TSHR (1.00) | TSHRTP53CYP2C9PDE4ALMNA | |
| Cadaverine Tartrate SCHEMBL116846 | 1.00 | TSHR (1.00) | TSHRTP53CYP2C9PDE4ALMNA | |
| Cadaverine Tartrate SCHEMBL29382062 | 1.00 | TSHR (1.00) | TSHRTP53CYP2C9PDE4ALMNA | |
| Cadaverine Tartrate SCHEMBL31427568 | 1.00 | TSHR (1.00) | TSHRTP53CYP2C9PDE4ALMNA | |
| Tartaric Acid SCHEMBL5762 | 1.00 | TSHR (1.00) | TSHRTP53CYP2C9PDE4ALMNA | |
| Cadaverine Tartrate SCHEMBL1431070 | 1.00 | TSHR (1.00) | TSHRTP53CYP2C9PDE4ALMNA | |
| Cadaverine Tartrate SCHEMBL3065246 | 1.00 | TSHR (1.00) | TSHRTP53CYP2C9PDE4ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 953151 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6410494-B1 | — | — | None | — | — | US | claimed |
| US-6413923-B1 | — | — | None | — | — | US | claimed |
| US-9974731-B2 | Method for producing functional lubricant and particulate material set used in the method | MEDICAL ARC CO., LTD. (JP) | 2018-05-22 | — | — | US | claimed |
| US-9976104-B2 | Antiwear composition and method of lubricating driveline device | THE LUBRIZOL CORPORATION (US) | 2018-05-22 | — | — | US | claimed |
| US-9977356-B2 | Cold pressure fix toner compositions based on crystalline polyester and amorphous organic compound mixtures | XEROX CORPORATION (US) | 2018-05-22 | — | — | US | claimed |
| US-9975847-B2 | Amino acid derivatives and their uses | JOHNSON & JOHNSON CONSUMER INC. (US) | 2018-05-22 | — | — | US | claimed |
| US-20180133133-A1 | STRUCTURED CRYSTALLINE SURFACTANT COMPOSITIONS | EVONIK OPERATIONS GMBH (DE) | 2018-05-17 | — | — | US | claimed |
| US-20180134658-A1 | SALTS AND PRODRUGS OF 1-METHYL-D-TRYPTOPHAN | LUMOS PHARMA, INC. | 2018-05-17 | — | — | US | claimed |
| WO-2018087103-A1 | HAIR TREATMENT COMPOSITIONS COMPRISING A HOMOPOLYMER OF (3-ACRYLAMIDOPROPYL) TRIMETHYL AMMONIUM CHLORIDE | UNILEVER PLC (GB) | 2018-05-17 | — | — | WO | claimed |
| WO-2018087181-A1 | METHOD FOR MAKING END COMPOUNDS FROM INTERNAL KETONES ISSUED FROM THE DECARBOXYLATIVE KETONIZATION OF FATTY ACIDS OR FATTY ACID DERIVATIVES | RHODIA OPERATIONS (FR) | 2018-05-17 | — | — | WO | claimed |
| US-3938531-A | Smoking material and the process of making the same | TAMAG BASEL AG. (CH) | 1976-02-17 | — | — | US | claimed |
| US-3939145-A | VIRICIDE | STRATEGIC MEDICAL RESEARCH CORPORATION (US) | 1976-02-17 | — | — | US | claimed |
| US-3939146-A | VIRICIDE | STRATEGIC MEDICAL RESEARCH CORPORATION (US) | 1976-02-17 | — | — | US | claimed |
| US-3937808-A | SUN TANNING AND HARI PROTECTING ACID SALTS OF AMINOMETHYL-O-HYDROXYPHENONES COMPOSITIONS | GAF CORPORATION (US) | 1976-02-10 | — | — | US | claimed |
| US-3937672-A | PLASTICIZING, CROSSLINKING WITH CYCLIC UREA COMPOUND | HOECHST AKTIENGESELLSCHAFT (DT) | 1976-02-10 | — | — | US | claimed |
| US-3937805-A | METHOD OF MAKING DENTIFRICE COMPOSITIONS CONTAINING INSOLUBILIZED SALTS OF 1,6-DI-(P-CHLOROPHENYL BIGUANIDO) HEXANE | COLGATE-PALMOLIVE COMPANY (US) | 1976-02-10 | — | — | US | claimed |
| US-3936313-A | Method of preparing additives for calcium sulphate plaster | MODOKEMI AB (SW) | 1976-02-03 | — | — | US | claimed |
| US-3934594-A | Process for the manufacture of tobacco substitute | TAMAG BASEL AG (CH) | 1976-01-27 | — | — | US | claimed |
| US-3933274-A | Product for the treatment of cellulosic fabrics | LEVER BROTHERS COMPANY (US) | 1976-01-20 | — | — | US | claimed |
| US-3931552-A | Capacitor electrolyte | P. R. MALLORY & CO., INC. (US) | 1976-01-06 | — | — | US | claimed |